ATE483708T1 - PYRROLOPYRIDINE-2-CARBONIC ACID HYDRAZIDES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE - Google Patents

PYRROLOPYRIDINE-2-CARBONIC ACID HYDRAZIDES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE

Info

Publication number
ATE483708T1
ATE483708T1 AT05717953T AT05717953T ATE483708T1 AT E483708 T1 ATE483708 T1 AT E483708T1 AT 05717953 T AT05717953 T AT 05717953T AT 05717953 T AT05717953 T AT 05717953T AT E483708 T1 ATE483708 T1 AT E483708T1
Authority
AT
Austria
Prior art keywords
inhibitors
glycogen phosphorylase
pyrrolopyridine
carbonic acid
acid hydrazides
Prior art date
Application number
AT05717953T
Other languages
German (de)
Inventor
Stuart Bradley
Revathy Jeevaratnam
Thomas Krulle
Martin Procter
Robert Rowley
Gerard Thomas
Ana Valdes
Original Assignee
Prosidion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosidion Ltd filed Critical Prosidion Ltd
Application granted granted Critical
Publication of ATE483708T1 publication Critical patent/ATE483708T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Compounds of Formula (I) or pharmaceutically acceptable salts thereof, are inhibitors of glycogen phosphorylase and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis or tissue ischemia e.g. myocardial ischemia, or as cardioprotectants or inhibitors of abnormal cell growth.
AT05717953T 2004-03-08 2005-03-08 PYRROLOPYRIDINE-2-CARBONIC ACID HYDRAZIDES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE ATE483708T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55125404P 2004-03-08 2004-03-08
PCT/GB2005/000885 WO2005085245A1 (en) 2004-03-08 2005-03-08 Pyrrolopyridine-2-carboxylic acid hydrazides

Publications (1)

Publication Number Publication Date
ATE483708T1 true ATE483708T1 (en) 2010-10-15

Family

ID=34919586

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05717953T ATE483708T1 (en) 2004-03-08 2005-03-08 PYRROLOPYRIDINE-2-CARBONIC ACID HYDRAZIDES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE

Country Status (7)

Country Link
US (1) US7884112B2 (en)
EP (1) EP1725555B1 (en)
JP (1) JP2007527904A (en)
AT (1) ATE483708T1 (en)
DE (1) DE602005023965D1 (en)
ES (1) ES2353309T3 (en)
WO (1) WO2005085245A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090298745A1 (en) * 2004-12-02 2009-12-03 Gerard Hugh Thomas Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
PE20080251A1 (en) 2006-05-04 2008-04-25 Boehringer Ingelheim Int USES OF DPP IV INHIBITORS
JP5277407B2 (en) * 2007-12-14 2013-08-28 名古屋市 Nucleating agent for polylactic acid and polylactic acid resin composition
PA8854101A1 (en) 2008-12-18 2010-07-27 Ortho Mcneil Janssen Pharm IMIDAZOL BICYCLIC DERIVATIVES REPLACED AS MODULATORS OF GAMMA SECRETASA
EA019685B1 (en) 2009-02-06 2014-05-30 Янссен Фармасьютикалз, Инк. Novel substituted bicyclic heterocyclic compounds as gamma secretase modulators
TWI461425B (en) 2009-02-19 2014-11-21 Janssen Pharmaceuticals Inc Novel substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators
BRPI1011190A8 (en) 2009-05-07 2016-11-16 Janssen Pharmaceuticals Inc SUBSTITUTED INDAZOLE AND AZA-INDAZOLE DERIVATIVES AS GAMMA SECRETASE MODULATORS
ES2519565T3 (en) 2009-07-15 2014-11-07 Janssen Pharmaceuticals Inc. Triazole and imidazole derivatives substituted as gamma secretase modulators
EP2523949B1 (en) 2010-01-15 2014-08-20 Janssen Pharmaceuticals Inc. Novel substituted triazole derivatives as gamma secretase modulators
CA2827969A1 (en) 2011-03-24 2012-09-27 Janssen Pharmaceuticals, Inc. Novel substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators
TWI567079B (en) 2011-07-15 2017-01-21 健生醫藥公司 Novel substituted indole derivatives as gamma secretase modulators
NZ702611A (en) 2012-05-16 2016-10-28 Cellzome Ltd Substituted 3, 4 - dihydro - 2h - pyrido [1, 2 -a] pyrazine - 1, 6 - dione derivatives useful for the treatment of (inter alia) alzheimer’s disease
AU2013366668B2 (en) 2012-12-20 2017-07-20 Janssen Pharmaceutica Nv Novel tricyclic 3,4-dihydro-2H-pyrido[1,2-alpha]pyrazine -1,6-dione derivatives as gamma secretase modulators
ES2612215T3 (en) 2013-01-17 2017-05-12 Janssen Pharmaceutica, N.V. Novel substituted pyrido-piperazinone derivatives as gamma secretase modulators
US10562897B2 (en) 2014-01-16 2020-02-18 Janssen Pharmaceutica Nv Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8618188D0 (en) 1986-07-25 1986-09-03 Ici Plc Diamine compounds
US5346907A (en) 1988-04-05 1994-09-13 Abbott Laboratories Amino acid analog CCK antagonists
GB8813356D0 (en) 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
US5672582A (en) 1993-04-30 1997-09-30 Merck & Co., Inc. Thrombin inhibitors
US5821241A (en) 1994-02-22 1998-10-13 Merck & Co., Inc. Fibrinogen receptor antagonists
US5885967A (en) 1994-03-04 1999-03-23 Eli Lilly And Company Antithrombotic agents
US5756810A (en) 1994-03-11 1998-05-26 Pharmacopeia, Inc. Process of preparing 3-nitro benzoate compounds in lower alkanol
GB9408117D0 (en) 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB2292149A (en) 1994-08-09 1996-02-14 Ferring Res Ltd Peptide inhibitors of pro-interleukin-1beta converting enzyme
US5618792A (en) 1994-11-21 1997-04-08 Cortech, Inc. Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
US6001811A (en) 1994-11-21 1999-12-14 Cortech Inc. Serine protease inhibitors--N-substituted derivatives
TW394764B (en) 1995-02-14 2000-06-21 Mitsubishi Chemcal Corp Oxygen-containing heterocyclic derivatives
DE19516483A1 (en) 1995-05-05 1996-11-07 Merck Patent Gmbh Adhesion receptor antagonists
WO1996036595A1 (en) 1995-05-19 1996-11-21 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
DE69523182T2 (en) 1995-06-06 2002-02-07 Pfizer SUBSTITUTED N- (INDOL-2-CARBONYL) GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS
FI974437A7 (en) 1995-06-06 1997-12-05 Pfizer Substituted N-(indole-2-carbonyl)amides and derivatives as glycogen phosphorylase inhibitors
EP0849256B1 (en) 1995-08-22 2005-06-08 Japan Tobacco Inc. Amide compounds and use of the same
EP0761680A3 (en) 1995-09-12 1999-05-06 Ono Pharmaceutical Co., Ltd. Tetrazole compounds having Interleukin-1beta converting enzyme inhibitory activity
IL119466A (en) 1995-11-03 2001-08-26 Akzo Nobel Nv Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
JP2000500461A (en) 1995-11-13 2000-01-18 スミスクライン・ビーチャム・コーポレイション Blood regulatory compounds
US6107309A (en) 1995-11-13 2000-08-22 Smithkline Beecham Corporation Hemoregulatory compounds
FR2744361B1 (en) 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa APPLICATION OF PYRROLIDINE DERIVATIVES TO THE PREPARATION OF DRUGS FOR THE TREATMENT OF DRUG ABUSE OR SUBSTANCES GIVEN TO PHARMACOMANIES OR EXCESSIVE USE
CZ291690B6 (en) 1996-02-13 2003-05-14 Akzo Nobel N. V. Serine protease inhibitors and pharmaceutical composition
WO1997031016A2 (en) 1996-02-23 1997-08-28 Ariad Pharmaceuticals, Inc. New inhibitors of sh2-mediated processes
IL120310A (en) 1996-03-01 2002-02-10 Akzo Nobel Nv Serine protease inhibitors and pharmaceutical compositions containing them
US5952322A (en) 1996-12-05 1999-09-14 Pfizer Inc. Method of reducing tissue damage associated with non-cardiac ischemia using glycogen phosphorylase inhibitors
AU5522498A (en) 1996-12-13 1998-07-03 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
WO2000077027A2 (en) 1999-06-14 2000-12-21 Tularik Limited Serine protease inhibitors
WO2000006550A1 (en) 1998-07-31 2000-02-10 Nippon Soda Co., Ltd. Phenylazole compounds, process for producing the same and drugs for hyperlipemia
UA73492C2 (en) 1999-01-19 2005-08-15 Aromatic heterocyclic compounds as antiinflammatory agents
AU4796700A (en) 1999-05-13 2000-12-05 Dupont Pharmaceuticals Research Laboratories, Inc. Ureido-substituted cyclic amine derivatives and their use as drug
CA2373942A1 (en) 1999-05-18 2000-11-23 Teijin Limited Remedies or prophylactis for diseases in association with chemokines
AU5920400A (en) 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Cell-based assay systems for examining hcv ns3 protease activity
CA2378499A1 (en) 1999-08-04 2001-02-15 Teijin Limited Cyclic amine ccr3 antagonists
ATE257480T1 (en) 1999-09-30 2004-01-15 Pfizer Prod Inc BICYCLIC PYRROLYLAMIDES AS GLYCOGEN PHOSPHORYLASE INHIBITORS
SE9903998D0 (en) 1999-11-03 1999-11-03 Astra Ab New compounds
JP2003523356A (en) 2000-01-29 2003-08-05 エルジー シーアイ リミテッド Factor Xa inhibitors with aryl-amidines, their derivatives, and their prodrugs
US6797504B1 (en) 2000-09-08 2004-09-28 Dendreon San Diego Llc Inhibitors of serine protease activity of matriptase or MTSP1
DE60107803T2 (en) 2000-02-23 2006-01-19 Zealand Pharma A/S NEW ANTIARRYTHMIC PEPTIDES
PE20011184A1 (en) 2000-03-16 2001-11-15 Pfizer Prod Inc PHARMACEUTICAL COMPOSITIONS OF GLUCOGENO-PHOSPHORYLASE INHIBITORS
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
AU2001269769A1 (en) 2000-06-07 2001-12-17 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Methods for making bis-heterocyclic alkaloids
WO2001096346A1 (en) 2000-06-14 2001-12-20 Eli Lilly And Company Tricyclic compounds as mrp1-inhibitors
IL144507A0 (en) 2000-07-31 2002-05-23 Pfizer Prod Inc Use of glycogen phosphorylase inhibitors to inhibit tumor growth
US6277877B1 (en) 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
AU2001279612A1 (en) 2000-08-18 2002-03-04 H. Lundbeck, A/S Substituted polyamine compounds
CA2321348A1 (en) 2000-09-27 2002-03-27 Blaise Magloire N'zemba Aromatic derivatives with hiv integrase inhibitory properties
GB2369117A (en) 2000-11-17 2002-05-22 Warner Lambert Co Bombesin receptor antagonists
PL362320A1 (en) 2000-12-06 2004-10-18 Aventis Pharma Deutschland Gmbh Guanidine and amidine derivatives as factor xa inhibitors
US20050054696A1 (en) 2001-10-29 2005-03-10 Takeshi Nakamura Indole compounds and medicinal use thereof
NZ543482A (en) 2003-05-21 2009-02-28 Prosidion Ltd Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase
WO2004113345A1 (en) 2003-06-20 2004-12-29 Japan Tobacco Inc. Fused pyrrole compound and medicinal use thereof

Also Published As

Publication number Publication date
WO2005085245A1 (en) 2005-09-15
ES2353309T3 (en) 2011-03-01
WO2005085245A8 (en) 2005-11-10
US7884112B2 (en) 2011-02-08
EP1725555A1 (en) 2006-11-29
JP2007527904A (en) 2007-10-04
DE602005023965D1 (en) 2010-11-18
EP1725555B1 (en) 2010-10-06
US20080269277A1 (en) 2008-10-30

Similar Documents

Publication Publication Date Title
NO20055305L (en) Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phosphorylase
ATE483708T1 (en) PYRROLOPYRIDINE-2-CARBONIC ACID HYDRAZIDES AS INHIBITORS OF GLYCOGEN PHOSPHORYLASE
TW200718424A (en) Novel compounds of amino sulfonyl derivatives
NO20072223L (en) Glycogen phosphorylase inhibitor compounds with pharmaceutical compositions thereof
NO20072608L (en) Biaryloksymetylarenkarboksylsyrer
NO20071320L (en) Pyrazole-substituted amino heteroaryl compounds as protein kinase inhibitors.
NO20084418L (en) Azolopyridin-3-one derivatives as inhibitors of endothelial lipase
EA200970161A1 (en) DERIVATIVES 1 - (- D-GLYCOPHRANOSYL) -3- (4-CYCLOPROPYLPHENYLMETHYL) -4-HALOGENOINDOL AND THEIR APPLICATION AS SGLT INHIBITORS
NO20082834L (en) 2- (phenyl or heterocyclic) -1H-phenanthro [9,10-D] imidazoles as MPGES-1 inhibitors
NO20065260L (en) Tri (cyclo) substituted amide compounds
EA200800172A1 (en) 2,4-DIAMINOPYRIMIDINES AS AURORA INHIBITORS
NO20045677L (en) Inhibitors of JAK and CDK2 protein kinases
NO20081846L (en) Biphenyl derivatives and their use in the treatment of hepatitis C
NO20063925L (en) Indazole derivatives as inhibitors of hormone-sensitive lipase
NO20080010L (en) GPCR agonists
NO20082445L (en) Neuropeptide-2 receptor agonists
NO20051103L (en) Indole-3-carboxamides as Glucokinase (GK) Activators
NO20074275L (en) 2- (4-oxo-4H-quinazolin-3-yl) acetamides and their use as vasopressin V3 antagonists
EA200802329A1 (en) TRIAZOLE DERIVATIVES II
WO2010036613A8 (en) Novel cyclic benzimidazole derivatives useful anti-diabetic agents
MXPA05010210A (en) Non-nucleoside reverse transcriptase inhibitors i for treating hiv mediated diseases.
ATE384058T1 (en) THIAZOLE DERIVATIVES
DE60215028D1 (en) INDOL DERIVATIVES AS BETA-3-ADRENERGE AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES
ATE424821T1 (en) PYRROLOPYRIDINE-2-CARBONIC ACID AMIDES
NO20065075L (en) Non-nucleoside-based reverse transcriptase inhibitors.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties